Transcatheter aortic valve implantation: The first applications and early results in Turkey

Objective & Hypothesis:Objectives: The objective of this study was to evaluate the first applications and results of transcatheter aortic valve implantation (TAVI) in Turkey, which is a new technology for the treatment of aortic valve stenosis.

📊

Key Findings & Data:Study design: We performed TAVI in eight severely symptomatic patients (5 women, 3 men; mean age 81.6±6.7 years; range 71 to 95 years) between May 1 and December 31, 2009.

💡

Conclusion & Impact:Following TAVI, the mean aortic valve area increased to 1.5±0.1 cm2 (p

🔬Design:Research Article

📍Scope:2009 Verileri

⚙️Variables:Domain Parameters

Abstract

Objectives: The objective of this study was to evaluate the first applications and results of transcatheter aortic valve implantation (TAVI) in Turkey, which is a new technology for the treatment of aortic valve stenosis. Study design: We performed TAVI in eight severely symptomatic patients (5 women, 3 men; mean age 81.6±6.7 years; range 71 to 95 years) between May 1 and December 31, 2009. All the patients had severe aortic stenosis (mean valve area 0.6 cm2, systolic peak/mean gradients 80.5±22.1/50.0±16.1 mmHg). Two patients had severe coronary artery disease that required intervention during TAVI. All the patients presented a high surgical risk (EuroSCORE 31.1±9.8 and STS score 12.8±7.9). The Edwards Sapien bioprosthetic valve was implanted through the transfemoral approach in seven patients, and transapical approach in one patient. Results: All prosthetic valves were of appropriate size, were implanted in appropriate locations, and functioned perfectly. Two patients with severe coronary stenosis underwent successful simultaneous percutaneous coronary intervention before TAVI. Following TAVI, the mean aortic valve area increased to 1.5±0.1 cm2 (p

Özet

Amaç: Bu çalışmada, aort kapak darlığı tedavisinde yeni bir teknoloji olan transkateter aort kapak yerleştirme (TAKY) yönteminin Türkiye’deki ilk uygulamaları ve sonuçları değerlendirildi.Çalışma planı: Hastanemizde 1 Mayıs-31 Aralık 2009 tarihleri arasında toplam sekiz hastaya (5 kadın, 3 erkek; ort. yaş 81.6±6.7; dağılım 71-95) kritik aort darlığı nedeniyle TAKY yapıldı. Hastaların hepsi ileri derecede semptomatik idi. Aort kapak alanı ortalama 0.6 cm2, sistolik/ortalama aort gradiyenti 80.5±22.1/50.0±16.1 mmHg idi. İki olguda ek olarak TAKY işlemi sırasında girişim gerektiren ciddi koroner arter hastalığı vardı. Tüm hastalarda cerrahi tedavi yüksek riskli bulunmuştu (EuroSCORE 31.1±9.8, STS skoru 12.8±7.9). Yedi hastaya transfemoral, bir hastaya transapikal yolla Edwards Sapien biyoprotez kapak takıldı.Bulgular: Hastaların hepsinde uygun ölçüdeki kapaklar, uygun pozisyonda yerleştirildi ve tüm kapaklar mükemmel fonksiyon gösterdi. İki hastada ciddi koroner darlık nedeniyle TAKY öncesinde eşzamanlı başarılı perkütan koroner girişim yapıldı. İşlem sonrasında ortalama aort kapak alanı 1.5±0.1 cm2 ölçüldü (p

🔖

Cite This Article

AKÇEVİN, A., TÜRKOĞLU, H., SEZER, A., PAKER, T., AKPEK, S., ÖZYİĞİT, T., YÜCEL, G., ERYILMAZ, A., SEZER, A., CRIBIER, A. (2022). Transcatheter aortic valve implantation: The first applications and early results in Turkey. Türk Kardiyoloji Derneği Arşivi, Cilt: 38 - Sayı: 4, 258–263. https://ajindex.com/articles/633231

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (14)

Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316-26
ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 1998;32:1486-588
Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, et al. The effect of aortic valve replacement on survival. Circulation 1982;66:1105 10
Bloomstein LZ, Gielchinsky I, Bernstein AD, Parsonnet V, Saunders C, Karanam R, et al. Aortic valve replacement in geriatric patients: determinants of in-hospital mortality. Ann Thorac Surg 2001;71:597-600
Kolh P, Kerzmann A, Lahaye L, Gerard P, Limet R. Cardiac surgery in octogenarians; peri-operative outcome and long-term results. Eur Heart J 2001;22:1235-43
Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8
Thielmann M, Wendt D, Eggebrecht H, Kahlert P, Massoudy P, Kamler M, et al. Transcatheter aortic valve implantation in patients with very high risk for conventional aortic valve replacement. Ann Thorac Surg 2009;88:1468-74
Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J 2003;24:881-2
Edwards FH, Grover FL, Shroyer AL, Schwartz M, Bero J. The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Ann Thorac Surg 1997;63:903-8
Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714-20
Lieberman EB, Bashore TM, Hermiller JB, Wilson JS, Pieper KS, Keeler GP, et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J Am Coll Cardiol 1995;26:1522-8
Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol 2009; 53:1829-36
Mack MJ. Transapical aortic valve implantation: is it ready for prime time? Eur J Cardiothorac Surg 2009;36:229-30
Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, et al. Treatment of calcific aortic sten